Industry News
New paste prevents scarring caused by radiation therapy for cancer
1/05/2016
An antiscarring paste when applied to the skin of mice halts fibrosis caused by the radiation used in cancer therapy.
Tumor suppressor gene promotes some colorectal cancers
1/05/2016
Sprouty2, a gene known to suppress spread of breast, prostate and liver cancer to other parts of the body - metastasis - may actually do the opposite in some colorectal cancers.
Recurrent acute and chronic pancreatitis in children has high disease burden, health care costs
1/05/2016
The burden of recurrent acute and chronic pancreatitis in children may be higher than previously thought, with high costs related to repeated hospitalizations, report a pair of studies in the...
Clues to Irish origins revealed by genome sequencing
1/05/2016
Genome sequencing has revealed new clues as to the origins of Irish people and culture, as well as health conditions such as hemochromatosis, common to people of Celtic origin.
For adult survivors of childhood cancer, cardiovascular disease presents at an earlier age, is associated with substantial morbidity, and is often asymptomatic.
Prostate surgery patients may have unrealistic expectations concerning their recovery
1/04/2016
Patients who have undergone radical prostatectomy often have largely unrealistic expectations with regard to their postoperative sexual function, new research shows.
Study links high sugar intake to increased risk of breast cancer
1/04/2016
Mice fed a diet enriched with sucrose or fructose were more likely to develop breast cancer and have the disease spread to the lungs, according to the results of a new study.
Quickly identifying tumors by using antibodies
1/04/2016
Antibodies combat viruses and bacteria. They also attach themselves to cancer cells - in a typical, characteristic way.
Cancer drug discovery gets a boost from large 3D database
1/04/2016
A 3D database that identifies 3 million surface structures on 110,000 cancer-causing molecules promises to boost development of new cancer drugs and treatments.
FDA approved investigational new drug for NBTXR3 in a new clinical study in prostate cancer
1/04/2016
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces the US Food and Drug Administration (FDA) has approved the Company's...